News & Articles

The investigational drug led to objective response and disease control in patients with late-stage disease

Responses were seen in patients who were not treated with prior KRAS G12C inhibitors as well as those whose disease progressed on prior KRAS G12C inhibitors

An updated trial analysis presented at AACR 2026 showed that the investigational KRAS G12D inhibitor zoldonrasib demonstrated clinical activity with a favorable safety profile in previously treated KRAS G12D‑mutant NSCLC patients

Extended immunotherapy showed manageable long‑term safety in adolescents and young adults with alveolar soft part sarcoma, according to phase II data presented at AACR 2026

Expanded antibody portfolio enhances detection of biologics and YTE-modified therapeutics for bioanalytical applications

Povair Sciences addresses critical bottlenecks in mAb development with innovative filtration solutions

Signals BioDesign is a cloud-native molecular cloning solution that enables high-throughput construct design (up to 1,000 constructs) with real-time data sharing

SPINRAZA is an antisense oligonucleotide therapy that increases production of survival motor neuron (SMN) protein, essential for motor neuron function

The technology selectively shuts down cancer reproducing cells

Boehringer Ingelheim expands its collaboration with OpenProtein.AI following successful initial deployment, co-developing integrated workflows for next-generation therapeutic development

Strategic collaboration integrates organ-on-chip technology into preclinical glioblastoma research to improve translational relevance

Forge Editing is a technique which uses no CRISPR proteins, but still benefits from the reprogrammability allowed by an RNA targeting region

New imaging model in the PerkinElmer Spotlight Aurora family, the Aurora-I, brings powerful smart adaptive IR imaging capabilities to FTIR microscopy analysis

Enables expression of active G-protein coupled receptors in 48 hours

Integrated cell line development platform enables biologics developers to accelerate time to clinic while maintaining regulatory confidence and commercial scalability

The Institute of Human Biology (IHB) enables scientists to pioneer human model systems, accelerating the development of new medicines to improve the lives of patients

ModulaSENSE Bitter can be applied across a wide range of oral dosage forms – including solid, liquid, and semi-solid formulations

A web-based tool designed to simplify instrument configuration and accelerate the quote request process

See how Life Science Group and Absolute Antibody partner to deliver a flexible antibody offering for future-focused life sciences research

Dale brings more than 30 years’ experience across the life sciences sector, with a background spanning bioprocessing, company building, and board leadership

StatLab and Thermo Fisher Scientific among those recognized

Twelve emerging life science startups to showcase enabling technologies at the SLAS European Conference and Exhibition in Vienna, May 19-21

By offering shared access to instrumentation and experienced cryo-EM scientists, the center allows companies to evaluate and incorporate the technology into existing workflows without building the infrastructure in-house

Michael Richardson explains how Inotiv is unlocking new insights into disease mechanisms and therapeutic effectiveness using spatial transcriptomics, proteomics, and AI-powered image analytics.

In an era where algorithmic hypothesis generation outpaces experimental validation capacity, the Centre of Excellence positions Arctoris at the critical interface between computational design and empirical truth